Most Wall Street analysts expect shares of Nvidia and Lam Research to soar in 2025. Nvidia's leadership in artificial ...

BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop ...

Honeywell International, the storied conglomerate which launched a strategic review early last year, announced plans Thursday to split into three independent companies.

On January 14, 2025, the Board approved a one-for-two-hundred (1:200) Reverse Split of the Common Stock. The Company anticipates that beginning with the opening of trading on February 10, 2025, the ...

Captain Pipes has delivered impressive long-term returns to investors through strategic actions like a 2:1 bonus issue and a ...

Dayton Judd, the Company’s Chairman and CEO, commented, “The 2-for-1 forward stock split aims to enhance the daily trading volumes of our common stock and reflects our confidence in the Company’s ...

A largely under-the-radar stock-split stock remains an amazing value amid a pricey market, while another highflier appears to be in a bubble.

BioXcel Therapeutics, Inc. (NASDAQ:BTAI), a pharmaceutical company with a market capitalization of $14.83 million, announced today the implementation of a 1-for-16 reverse stock split of its common ...

On rare occasions, our expert team of analysts issues a “Double Down” stock recommendation for companies that they think are ...

Algorhythm Holdings, Inc. (NASDAQ:RIME), a Delaware-incorporated company specializing in phonograph records and prerecorded audio tapes and disks, announced today a significant change to its capital ...